| |
|
|
|
| |
Meeting Challenges in Contract R&D BioPharm International March 2012
Representatives from leading contract research organizations (CROs) weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more. Charles River’s Nancy Gillett, PhD, corporate executive vice-president and president of Global Preclinical Services, participated in this roundtable.
Click here to read the full article.
|
|
BioPharm International, BioPharm, contract research, CRO, CROs, R&D, biopharmaceutical, biopharmaceuticals, bioequivalence, process analytics, Nancy Gillett
Meeting Challenges in Contract R&D | BioPharm International (March 2012)
Representatives from leading contract research organizations (CROs) weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more.